Latest Breaking News On - Supplemental new drug application - Page 4 : comparemela.com

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Katherine mirandaJohn tuckerYork heart associationPharmaceuticals incExchange commissionCompany annual report on formPivotal pharmacokinetic studySupplemental new drug applicationOn body infusorChief executive officerNew york heart associationPrescribing informationPrivate securities litigation reform actInjector injectionBody infusorAnnual report

FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer

FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMeichiel keenandirectorRahul aggarwalDavid deluciaDeyaa adibCorporate communicationsFibrogen incExchange commissionDrug administrationAmerican society for clinical oncologyChina health authorityFortis therapeutics sponsored phaseChief medical officerCalifornia san franciscoLead investigatorAmerican society

FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer

FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDeyaa adibMeichiel keenanDavid deluciaRahul aggarwalFibrogen incExchange commissionDrug administrationChina health authorityCorporate communicationsAmerican society for clinical oncologyFortis therapeutics sponsored phaseChief medical officerCalifornia san franciscoLead investigatorAmerican society

FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer

FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMeichiel keenanDavid deluciaDeyaa adibRahul aggarwalExchange commissionDrug administrationAmerican society for clinical oncologyChina health authorityCorporate communicationsFibrogen incGen announces topline resultsMetastatic castration resistant prostateFortis therapeutics sponsored phaseChief medical officerCalifornia san francisco

FibroGen to Present at 23rd Annual Needham Virtual Healthcare Conference - FibroGen (NASDAQ:FGEN)

SAN FRANCISCO, March 26, 2024 (GLOBE NEWSWIRE) FibroGen, Inc. (NASDAQ:FGEN) today announced that Thane Wettig, Chief Executive Officer, will participate in a corporate presentation at the 23rd Annual Needham Virtual

Meichiel keenanDavid deluciaCorporate communicationsChina health authorityFibrogen incThane wettigChief executive officerAnnual needham virtual healthcare conferenceFibrogen investorSupplemental new drug applicationChina healthInvestor relations